Masafuchi Ryo

401 total citations
13 papers, 316 citations indexed

About

Masafuchi Ryo is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Masafuchi Ryo has authored 13 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in Masafuchi Ryo's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Peripheral Neuropathies and Disorders (3 papers) and Neurological disorders and treatments (3 papers). Masafuchi Ryo is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Peripheral Neuropathies and Disorders (3 papers) and Neurological disorders and treatments (3 papers). Masafuchi Ryo collaborates with scholars based in Japan and Czechia. Masafuchi Ryo's co-authors include Fumihito Yoshii, Wakoh Takahashi, Yusuke Moriya, Naoji Amano, Saburo Yagishita, Kazuko Hasegawa, Masayuki Inoue, Masaaki Matsushita, Jun Hashimoto and Takashi Koide and has published in prestigious journals such as Human Molecular Genetics, Acta Neuropathologica and Journal of the Neurological Sciences.

In The Last Decade

Masafuchi Ryo

13 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masafuchi Ryo Japan 9 208 90 82 69 46 13 316
Ibán Aldecoa Spain 13 336 1.6× 51 0.6× 76 0.9× 58 0.8× 24 0.5× 48 564
Houyam Tibar Morocco 7 131 0.6× 53 0.6× 56 0.7× 84 1.2× 26 0.6× 17 276
Jerome Staal Australia 11 170 0.8× 119 1.3× 141 1.7× 31 0.4× 22 0.5× 12 402
Sachiyo Misumi Japan 11 88 0.4× 91 1.0× 102 1.2× 65 0.9× 25 0.5× 17 365
Zhentang Cao China 10 178 0.9× 32 0.4× 101 1.2× 82 1.2× 13 0.3× 16 351
Yuzhou Guan China 14 307 1.5× 71 0.8× 101 1.2× 43 0.6× 19 0.4× 42 461
D. N. Angelov Germany 6 176 0.8× 176 2.0× 39 0.5× 103 1.5× 61 1.3× 9 377
J Bèrciano Spain 11 82 0.4× 134 1.5× 61 0.7× 45 0.7× 23 0.5× 25 357
Matthew Wicklund United States 12 111 0.5× 127 1.4× 223 2.7× 23 0.3× 23 0.5× 34 412
Kirsten Erwin United States 6 293 1.4× 56 0.6× 157 1.9× 63 0.9× 13 0.3× 11 538

Countries citing papers authored by Masafuchi Ryo

Since Specialization
Citations

This map shows the geographic impact of Masafuchi Ryo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafuchi Ryo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafuchi Ryo more than expected).

Fields of papers citing papers by Masafuchi Ryo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafuchi Ryo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafuchi Ryo. The network helps show where Masafuchi Ryo may publish in the future.

Co-authorship network of co-authors of Masafuchi Ryo

This figure shows the co-authorship network connecting the top 25 collaborators of Masafuchi Ryo. A scholar is included among the top collaborators of Masafuchi Ryo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafuchi Ryo. Masafuchi Ryo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
3.
Yoshii, Fumihito, et al.. (2018). Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer’s disease. Neurological Sciences. 39(5). 909–918. 9 indexed citations
4.
Yoshii, Fumihito, et al.. (2017). 123 I-Meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients showing scans without evidence of dopaminergic deficits (SWEDDs). Clinical Neurology and Neurosurgery. 160. 73–77. 3 indexed citations
5.
Yoshii, Fumihito, Masafuchi Ryo, Yasuhiko Baba, Takashi Koide, & Jun Hashimoto. (2017). Combined use of dopamine transporter imaging (DAT-SPECT) and 123 I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease. Journal of the Neurological Sciences. 375. 80–85. 27 indexed citations
6.
Yoshii, Fumihito, et al.. (2017). Neurological safety of fingolimod: An updated review. Clinical and Experimental Neuroimmunology. 8(3). 233–243. 40 indexed citations
7.
Yoshii, Fumihito, et al.. (2017). MRI Signal Abnormalities of the Inferior Olivary Nuclei in Spinocerebellar Ataxia Type 2. Case Reports in Neurology. 9(3). 267–271. 4 indexed citations
8.
Yoshii, Fumihito, et al.. (2016). Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder. Multiple Sclerosis and Related Disorders. 7. 53–57. 26 indexed citations
9.
10.
Ohta, Etsuro, Tomoko Nihira, A Uchino, et al.. (2015). I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3β signaling pathway. Human Molecular Genetics. 24(17). 4879–4900. 56 indexed citations
11.
12.
13.
Ryo, Masafuchi, Toyokazu Saito, Naoto Kunii, Hirokazu Hasegawa, & Hisayuki Kowa. (1994). [A case of chronic inflammatory demyelinating polyneuropathy with recurrent ophthalmoplegia, persistent conduction block, antibody activity against gangliosides GM1].. PubMed. 34(7). 702–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ibán Aldecoa Breakdown of academic impact, for papers by Houyam Tibar Breakdown of academic impact, for papers by Jerome Staal Breakdown of academic impact, for papers by Sachiyo Misumi Breakdown of academic impact, for papers by Zhentang Cao Breakdown of academic impact, for papers by Yuzhou Guan Breakdown of academic impact, for papers by D. N. Angelov Breakdown of academic impact, for papers by J Bèrciano Breakdown of academic impact, for papers by Matthew Wicklund Breakdown of academic impact, for papers by Kirsten Erwin
Rankless by CCL
2026